$XENE Xenon Pharmaceuticals Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Xenon Pharmaceuticals Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Xenon Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Xenon Pharmaceuticals Inc. for free.

CIK Number: 0001582313
IRS Number: 980661854
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: XENE
Company Address: 200 - 3650 GILMORE WAY BURNABY V5G 48W

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Market Capitalization: $145.83M
Prev close: $8.20
Average Daily Volume: 44,169
Days Low: $8.15
Year Low: $5.65
Year High: $8.75

Xenon Pharmaceuticals Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 04 2021XENEXenon Pharmaceutic ...PATOU GARYDirectorOption ExerciseA18.5610,000185,60010,000
Jun 04 2021XENEXenon Pharmaceutic ...PATOU GARYDirectorBuyL19.491001,9491000 to 100
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...Option ExerciseM3.8513,37451,4900
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...Option ExerciseM3.7612,34546,4170
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...SellS18.812,91254,77532,23235.1 K to 32.2 K (-8.29 %)
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...SellS18.813,15559,34635,14438.3 K to 35.1 K (-8.24 %)
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...Payment of ExerciseF18.912,19241,45138,29940.5 K to 38.3 K (-5.41 %)
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...BuyM3.8513,37451,49040,49127.1 K to 40.5 K (+49.32 %)
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...Payment of ExerciseF18.912,02438,27427,11729.1 K to 27.1 K (-6.95 %)
Jun 01 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...BuyM3.7612,34546,41729,14116.8 K to 29.1 K (+73.50 %)
Mar 15 2021XENEXenon Pharmaceutic ...Von Seggern ChristopherChief Commercial Of ...Option ExerciseA20.5560,0001,233,00060,000
Mar 15 2021XENEXenon Pharmaceutic ...ROBIN SHERRINGTONEVP, Strategy & Inn ...Option ExerciseA20.5565,0001,335,75065,000
Mar 15 2021XENEXenon Pharmaceutic ...PIMSTONE SIMON N.CEOOption ExerciseA20.55225,0004,623,750225,000
Mar 15 2021XENEXenon Pharmaceutic ...MORTIMER IANPRESIDENT & CFOOption ExerciseA20.55100,0002,055,000100,000
Mar 15 2021XENEXenon Pharmaceutic ...EMPFIELD JAMES R.EVP, Drug DiscoveryOption ExerciseA20.5565,0001,335,75065,000

View all Xenon Pharmaceuticals Inc. insider transactions.